CNTB Earnings

Quarterly EPS
$0.27
Q2 2024
$-0.23
Q3 2024
$-0.17
Q4 2024
$-0.19
Q1 2025
$-0.23
Q2 2025
$-0.31
Q3 2025
$-0.28
Q4 2025
$-0.34
Q1 2026
Latest Revenue169.0K
Latest Net Income-19398000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.34169.0K-19398000-78.9%
Q4 2025-$0.280-15109000-100.0%-64.7%
Q3 2025-$0.3116.0K-17200000-98.7%-34.8%
Q2 2025-$0.2348.0K-12899000-99.8%-185.2%
Q1 2025-$0.19-10272000-18.8%
Q4 2024-$0.17698.0K-8906000
Q3 2024-$0.231.2M-12876000
Q2 2024$0.2724.1M14.8M
Q1 2024-$0.16-8693000
Connect Biopharma (CNTB) — Earnings